Invasive pneumococcal disease in children's hospitals: 2014–2017

SL Kaplan, WJ Barson, PL Lin, JR Romero… - …, 2019 - publications.aap.org
BACKGROUND: The 13-valent pneumococcal conjugate vaccine (PCV13) was licensed in
the United States in 2010. We describe invasive pneumococcal disease (IPD) in children at …

Invasive Pneumococcal Disease in Children's Hospitals: 2014-2017.

SL Kaplan, WJ Barson, PL Lin, JR Romero, JS Bradley… - Pediatrics, 2019 - europepmc.org
The 13-valent pneumococcal conjugate vaccine (PCV13) was licensed in the United States
in 2010. We describe invasive pneumococcal disease (IPD) in children at 8 children's …

Invasive Pneumococcal Disease in Children's Hospitals: 2014-2017

SL Kaplan, WJ Barson, PL Lin, JR Romero… - …, 2019 - pubmed.ncbi.nlm.nih.gov
Background The 13-valent pneumococcal conjugate vaccine (PCV13) was licensed in the
United States in 2010. We describe invasive pneumococcal disease (IPD) in children at 8 …

Invasive pneumococcal disease in children's hospitals: 2014-2017.

SL Kaplan, WJ Barson, LP Lin Ling [Lin, JR Romero… - 2019 - cabidigitallibrary.org
BACKGROUND: The 13-valent pneumococcal conjugate vaccine (PCV13) was licensed in
the United States in 2010. We describe invasive pneumococcal disease (IPD) in children at …

Invasive pneumococcal disease in children's hospitals: 2014-2017

SL Kaplan, WJ Barson, PL Lin, JR Romero… - …, 2019 - ohiostate.elsevierpure.com
BACKGROUND: The 13-valent pneumococcal conjugate vaccine (PCV13) was licensed in
the United States in 2010. We describe invasive pneumococcal disease (IPD) in children at …

Invasive pneumococcal disease in children's hospitals: 2014-2017

SL Kaplan, WJ Barson, PL Lin, JR Romero… - …, 2019 - scholars.northwestern.edu
BACKGROUND: The 13-valent pneumococcal conjugate vaccine (PCV13) was licensed in
the United States in 2010. We describe invasive pneumococcal disease (IPD) in children at …